IBA signs contract with Istituto Clinico Humanitas for a & More News Here

---

         

Louvain-La-Neuve, Belgium, June 30, 2022 – IBA (Ion Beam Applications S.A., EURONEXT), the world chief in particle accelerator expertise and the world’s main supplier of proton remedy options for the remedy of most cancers, in the present day publicizes it has signed a contract with Istituto Clinico Humanitas (Humanitas Research Hospital) for the set up of a Proteus^®ONE¹ compact proton remedy resolution in Rozzano (Milan), Italy. IBA will begin to acknowledge the income of this contract in 2022.

The proton remedy resolution can be put in on the Humanitas Cancer Center and consists of a Proteus^®ONE resolution in addition to a totally built-in high quality assurance (QA) {hardware} and software program bundle from IBA Dosimetry. The contract consists of long-term operation and upkeep companies to be supplied by IBA. Istituto Clinico Humanitas expects to begin treating sufferers by 2025.

The typical end-user worth for a Proteus^®ONE system with a 10-year upkeep contract ranges between EUR 35-45 million.

Olivier Legrain, Chief Executive Officer of IBA, commented: “This deal with Humanitas reinforces our position as a global market leader in proton therapy and further highlights the increase in activity that we are seeing in Europe and at the global scale. It is the third Proteus^®ONE deal secured in Italy and the fourth IBA proton therapy system sold in the country overall. Humanitas is renowned for its innovative cancer treatments, and we look forward to supporting the center in our joint mission of providing cancer patients with access to the most advanced treatment options.”

Luciano Ravera, Chief Executive Officer of Istituto Clinico Humanitas, added: “We are glad to partner with IBA to make increasingly advanced treatments available to our patients. The proton center will further enhance the services of the Humanitas Cancer Center, and in particular its radiotherapy team, which already takes care of thousands of patients from all over Italy and beyond. Proton therapy is an advanced and innovative form of radiotherapy and nowadays represents a new treatment choice for many types of cancer. Research collaborations will also benefit from this new service, enabling us to contribute to the development of international studies with the community of other proton therapy users.”

***ENDS***

About IBA

IBA (Ion Beam Applications S.A.) is the world chief in particle accelerator expertise. The firm is the main provider of apparatus and companies within the subject of proton remedy, thought-about to be probably the most superior type of radiation remedy obtainable in the present day. IBA can also be a main participant within the fields of business sterilization, radiopharmaceuticals and dosimetry. The firm, primarily based in Louvain-la-Neuve, Belgium, employs roughly 1,500 folks worldwide. IBA is a licensed B Corporation (B Corp) assembly the very best requirements of verified social and environmental efficiency.

IBA is listed on the pan-European inventory trade EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).

More data could be discovered at: www.iba-worldwide.com

About Humanitas

Humanitas is a extremely specialised hospital, analysis and educating heart, which hosts Humanitas University, an educational institute devoted to medical sciences. Built round facilities for the prevention and remedy of most cancers, cardiovascular, neurological, autoimmune, inflammatory, and orthopedic ailments, Istituto Clinico Humanitas additionally operates a extremely specialised Emergency Department and the Emergency Hospital 19, devoted to the remedy of infectious ailments. Humanitas is the primary Italian hospital quality-certified by Joint Commission International since 2018 as Academic Hospital, and it’s accredited by Italy’s National Health Service. Appointed as an IRCCS by the Ministry of Health (an accreditation within the Italian system that acknowledges establishments centered on excellence in scientific care and analysis), Humanitas is an internationally well-known analysis heart with concentrate on immune system-related ailments. Istituto Clinico Humanitas is the flagship of a hospital group additionally current in Milan, Bergamo, Turin, Catania and Castellanza (Varese).

More data could be discovered at : https://www.humanitas.it/

CONTACTS

Soumya Chandramouli
Chief Financial Officer
+32 10 475 890
[email protected]

Olivier Lechien
Corporate Communication Director
+32 10 475 890
[email protected]

Consilium Strategic Communications
Amber Fennell, Angela Gray, Lucy Featherstone
+44 (0) 20 3709 5700
[email protected]

¹ Proteus^®ONE is the model identify of Proteus^®235

 

• 220630_Humanitas_Contract-P1-Rozzano-EN-2

I’ve tried to provide every kind of stories to all of you latest news today 2022 by this web site and you’ll like all this information very a lot as a result of all of the information we at all times give on this information is at all times there. It is on trending subject and regardless of the newest information was

it was at all times our effort to achieve you that you simply maintain getting the most recent information and also you at all times maintain getting the knowledge of stories by us for free and likewise let you know folks. Give that no matter data associated to different varieties of information can be

made obtainable to all of you so that you’re at all times linked with the information, keep forward within the matter and maintain getting today news all varieties of information for free until in the present day so as to get the information by getting it. Always take two steps ahead